Tuesday, July 19th, 8-10 am ET
Please, join LBG’s Michael McGinnis, Managing Director, for an informative panel discussion at MassBio on non-dilutive government funding options. He will be joined by industry insiders who are also managing the grant and government funding processes and entrepreneurs who have also successfully obtained funding. Together, they will provide further insight into this important avenue for financing.
As biotech continues to expand and evolve, emerging companies look beyond traditional financing models to fund the scientific and business efforts needed for success. Not only is the competition for equity funding fierce, but there are also significant ramifications on company ownership and control. An increasing number of nonprofit organizations are both driving research with grant funding and seeking innovative sources of funding.
Accordingly, grants and government funding are becoming increasingly prevalent as a means to finance emerging companies. However, such grants and government funding can be:
- difficult to identify and obtain,
- often require knowledge of the inner workings of various funding sources and
- approval from expert stakeholders with deep domain knowledge.